Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines
Carolien van Alphen(Amsterdam University Medical Centers), Connie R. Jiménez(Amsterdam University Medical Centers)
Cited by 46
Related Papers
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma
|Cell Reports|2023|26
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines
|Molecular & Cellular Proteomics|2022|5
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active phosphokinases
|bioRxiv (Cold Spring Harbor Laboratory)|2018|3